Accessibility of pregnancy-related point-of-care diagnostic tests for maternal healthcare in rural primary healthcare facilities in Northern Ghana: A cross-sectional survey

Kuupiel, Desmond; Tlou, Boikhutso; Bawontuo, Vitalis; Mashamba-Thompson, Tivani P.

doi:10.1016/j.heliyon.2019.e01236

Cited by 24 publications

(39 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This is a follow-up study on a prior cross-sectional study conducted to assess the accessibility of pregnancy-related POC diagnostic tests in the upper east region (UER) of Ghana [29]. Of the 100 participated PHC clinics in the earlier study, none was providing G6PD deficiency testing services in the region [29]. This current study, therefore, mapped the geographical access to POC testing for G6PD deficiency as part of ANC services.…”

Section: Study Design and Settingmentioning

confidence: 99%

“…This current study, therefore, mapped the geographical access to POC testing for G6PD deficiency as part of ANC services. The study setting has been adequately described in the earlier published cross-sectional survey and audit [29,30]. The 2019 project population of the region is approximately 1,273,677 (51.6% females) and is considered largely (79%) rural and scattered in dispersed settlements [33].…”

Section: Study Design and Settingmentioning

confidence: 99%

“…We previously collected data on 100 randomly selected PHC clinics from all the districts in the UER as explained in the published cross-sectional survey [29]. We also collected data on all health facilities (district hospitals) providing G6PD deficiency testing in the region.…”

Section: Data Collectionmentioning

confidence: 99%

“…However, G6PD deficiency testing in Ghana is still a laboratory-based test (microscopy) and may not be accessible to all pregnant women particularly, those accessing ANC in rural primary healthcare (PHC) clinics. Although previous studies assessed the availability and supply chain management of point-of-care (POC) test including G6PD deficiency tests [29][30][31], geographical accessibility to comprehensive ANC POC testing [32], and evaluated a POC testing device for G6PD deficiency [5], to date, no study in Ghana has assessed the geographical accessibility to POC testing for G6PD deficiency. To inform national policy on G6PD deficiency screening test, support treatment decisions with anti-malarial medicines and SP administration to pregnant women in rural PHC clinics, the national malaria control or elimination program, and to improve equity to healthcare, we mapped the geographical access (distance and travel time) to POC testing for G6PD deficiency using geographical information systems.…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Geographical Accessibility to Glucose-6-Phosphate Dioxygenase Deficiency Point-of-Care Testing for Antenatal Care in Ghana

et al. 2020

Self Cite

View full text Add to dashboard Cite

Background: Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency screening test is essential for malaria treatment, control, and elimination programs. G6PD deficient individuals are at high risk of severe hemolysis when given anti-malarial drugs such as primaquine, quinine, other sulphonamide-containing medicines, and chloroquine, which has recently been shown to be potent for the treatment of coronavirus disease . We evaluated the geographical accessibility to POC testing for G6PD deficiency in Ghana, a malaria-endemic country. Methods: We obtained the geographic information of 100 randomly sampled clinics previously included in a cross-sectional survey. We also obtained the geolocated data of all public hospitals providing G6PD deficiency testing services in the region. Using ArcGIS 10.5, we quantified geographical access to G6PD deficiency screening test and identified clinics as well as visualize locations with poor access for targeted improvement. The travel time was estimated using an assumed speed of 20 km per hour. Findings: Of the 100 clinics, 58% were Community-based Health Planning and Services facilities, and 42% were sub-district health centers. The majority (92%) were Ghana Health Service facilities, and the remaining 8% were Christian Health Association of Ghana facilities. Access to G6PD deficiency screening test was varied across the districts, and G6PD deficiency screening test was available in all eight public hospitals. This implies that the health facility-to-population ratio for G6PD deficiency testing service was approximately 1: 159,210 (8/1,273,677) population. The spatial analysis quantified the current mean distance to a G6PD deficiency testing service from all locations in the region to be 34 ± 14 km, and travel time (68 ± 27 min). The estimated mean distance from a clinic to a district hospital for G6PD deficiency testing services was 15 ± 11 km, and travel time (46 ± 33 min). Conclusion: Access to POC testing for G6PD deficiency in Ghana was poor. Given the challenges associated with G6PD deficiency, it would be essential to improve access to G6PD deficiency POC testing to facilitate administration of sulphadoxine-pyrimethamine to pregnant women, full implementation of the malaria control program in Ghana, and treatment of COVID-19 patients with chloroquine in malaria-endemic countries. To enable the World Health Organization include appropriate G6PD POC diagnostic tests in its list of essential in-vitro diagnostics for use in resource-limited settings, we recommend a wider evaluation of available POC diagnostic tests for G6PD deficiency, particularly in malaria-endemic countries.

show abstract

Section: Study Design and Settingmentioning

confidence: 99%

Section: Study Design and Settingmentioning

confidence: 99%

Section: Data Collectionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Geographical Accessibility to Glucose-6-Phosphate Dioxygenase Deficiency Point-of-Care Testing for Antenatal Care in Ghana

et al. 2020

Self Cite

View full text Add to dashboard Cite

show abstract

“…Mobile health is an emerging and a promising way to improve disease prevention, diagnosis, treatment compliance, medication adherence and honouring clinic appointments thereby enhancing health outcomes (13). Mobile phone technology allows easy remote communication between health workers and their patients in hard-toreach communities with poor access to healthcare due to deplorable roads or transportation challenges (14)(15)(16). Previous studies have demonstrated that mHealth technologies have the capacity to improve healthcare outcomes such as health workers adhering to case management standards and guidelines (11,(17)(18)(19).…”

mentioning

confidence: 99%

Mapping Evidence of Mobile Health Technologies for Disease Diagnosis and Treatment Support by Health Workers in Sub-Saharan Africa: A Scoping Review

Osei

Kuupiel

Vezi

et al. 2019

Preprint

Self Cite

View full text Add to dashboard Cite

Background: The rapid growth of mobile technology has given rise to the development of mobile health programmes aimed at treating and preventing a wide range of health conditions. However, evidence on the use of mHealth in high disease burdened settings such as SSA is not clear. We systematically mapped evidence on mHealth for disease diagnosis and treatment support by health workers in SSA. Methods: We conducted a scoping review study guided by the Arksey and O’Malley’s framework, Levac et al recommendations, and Joanna Briggs Institute guidelines. We thoroughly searched the following databases: MEDLINE and CINAHL with full-text via EBSCOhost; PubMed; Science Direct and Google Scholar for relevant articles from inception to July 2019. Two independent reviewers screened abstracts and full-text articles using the eligibility criteria as reference. This study employed the mixed methods appraisal tool version 2018 to assess the methodological quality of the included studies. Results: Out of the 572 articles identified , only 10 published articles presented evidence on mHealth for treatment support by health workers in SSA since 2010. No studies reported evidence on mHealth for disease diagnosis by health workers in SSA. Of the 10 studies, four studies were conducted in Kenya; one in South Africa; one in Malawi; one in Zimbabwe; one in Mozambique; one in Nigeria and one in Lesotho. Of the 10 studies: three reported the use of mHealth to manage HIV; two on the management of HIV/TB; two on treatment of malaria; one each on the management of hypertension; cervical cancer; and one was not specific on any disease condition. All the 10 included studies underwent methodological quality appraisal with a scored between 70 and 100%. Conclusions: The study shows that there is limited research on the availability and use of mHealth by health workers for treatment support in SSA. This study also shows there is no literature on the availability and use of mHealth by health workers for disease diagnosis in SSA. We, therefore, recommend primary studies focusing on the use of mHealth by health workers for disease diagnosis in SSA. Keywords: Mobile Health; Disease diagnosis; Treatment support; sub-Saharan Africa

show abstract

Measuring access to health facilities in Ghana: Implications for implementation of health interventions and the Sustainable Development Goal 3

2023

View full text Add to dashboard Cite

Accessibility of pregnancy-related point-of-care diagnostic tests for maternal healthcare in rural primary healthcare facilities in Northern Ghana: A cross-sectional survey

Cited by 24 publications

References 31 publications

Geographical Accessibility to Glucose-6-Phosphate Dioxygenase Deficiency Point-of-Care Testing for Antenatal Care in Ghana

Geographical Accessibility to Glucose-6-Phosphate Dioxygenase Deficiency Point-of-Care Testing for Antenatal Care in Ghana

Mapping Evidence of Mobile Health Technologies for Disease Diagnosis and Treatment Support by Health Workers in Sub-Saharan Africa: A Scoping Review

Measuring access to health facilities in Ghana: Implications for implementation of health interventions and the Sustainable Development Goal 3

Contact Info

Product

Resources

About